Miwon Specialty Chemical Co., Ltd.
KRX:268280.KS
140800 (KRW) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 437,672.918 | 611,649.824 | 531,343.053 | 371,989.561 | 377,850.724 | 360,434.685 | 208,335.668 | 287,756.594 |
| Cost of Revenue
| 385,599.139 | 479,790.37 | 395,467.888 | 296,077.027 | 305,667.243 | 296,285.369 | 169,703.148 | 218,412.596 |
| Gross Profit
| 52,073.779 | 131,859.454 | 135,875.165 | 75,912.534 | 72,183.482 | 64,149.316 | 38,632.519 | 69,343.999 |
| Gross Profit Ratio
| 0.119 | 0.216 | 0.256 | 0.204 | 0.191 | 0.178 | 0.185 | 0.241 |
| Reseach & Development Expenses
| 4,100.207 | 4,638.225 | 4,628.649 | 4,356.085 | 5,016.838 | 4,738.389 | 3,137.198 | 3,942.776 |
| General & Administrative Expenses
| 825.56 | 733.431 | 624.905 | 404.917 | 850.512 | 791.309 | 459.819 | 0 |
| Selling & Marketing Expenses
| 18,899.231 | 36,786.039 | 26,894.973 | 14,921.679 | 13,296.456 | 12,031.426 | 8,880.762 | 0 |
| SG&A
| 25,686.782 | 37,519.471 | 27,519.877 | 15,326.596 | 14,146.968 | 12,822.736 | 9,340.581 | 24,726.312 |
| Other Expenses
| -211.441 | 8,848.309 | 8,694.521 | 7,021.672 | 6,431.672 | 2,441.183 | 305.003 | -210.612 |
| Operating Expenses
| 29,998.43 | 51,006.004 | 40,843.047 | 26,704.354 | 25,595.479 | 24,118.292 | 16,818.984 | 28,879.701 |
| Operating Income
| 22,075.349 | 80,853.45 | 95,032.118 | 49,208.181 | 46,588.003 | 40,031.024 | 21,813.536 | 40,464.298 |
| Operating Income Ratio
| 0.05 | 0.132 | 0.179 | 0.132 | 0.123 | 0.111 | 0.105 | 0.141 |
| Total Other Income Expenses Net
| 4,937.689 | 4,042.903 | 10,466.484 | -3,413.271 | 2,641.456 | 4,644.617 | -1,390.817 | 2,294.666 |
| Income Before Tax
| 27,013.038 | 84,896.353 | 105,498.602 | 45,794.91 | 49,229.459 | 44,675.64 | 20,422.718 | 42,758.965 |
| Income Before Tax Ratio
| 0.062 | 0.139 | 0.199 | 0.123 | 0.13 | 0.124 | 0.098 | 0.149 |
| Income Tax Expense
| 8,408.397 | 20,072.126 | 25,595.24 | 11,129.257 | 9,664.155 | 8,701.56 | 3,225.784 | 8,243.742 |
| Net Income
| 18,604.641 | 64,824.227 | 79,903.361 | 34,665.653 | 39,565.304 | 35,974.08 | 17,196.935 | 34,477.022 |
| Net Income Ratio
| 0.043 | 0.106 | 0.15 | 0.093 | 0.105 | 0.1 | 0.083 | 0.12 |
| EPS
| 3,758.22 | 12,932 | 15,897 | 6,768.94 | 7,559.15 | 6,932 | 3,321 | 489.28 |
| EPS Diluted
| 3,758.22 | 12,932 | 15,897 | 6,768.94 | 7,559.15 | 6,932 | 3,321 | 489.28 |
| EBITDA
| 50,741.555 | 106,125.652 | 122,362.731 | 62,878.229 | 65,916.436 | 59,060.465 | 27,808.052 | 51,207.699 |
| EBITDA Ratio
| 0.116 | 0.174 | 0.23 | 0.169 | 0.174 | 0.164 | 0.133 | 0.178 |